-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Sector Perform on Agios Pharmaceuticals, Raises Price Target to $32

Benzinga·07/07/2026 15:47:06
Listen to the news
RBC Capital analyst Luca Issi maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Sector Perform and raises the price target from $28 to $32.